Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Alimentary Pharmacology & Therapeutics|August 19, 2015
Treating ischaemia-reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantationA Kornberg, U Witt, J Kornberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2009
Recurrence-free long-term survival after liver transplantation in patients with 18F-FDG non-avid hilar cholangiocarcinoma on PETA Kornberg, B Küpper, K Thrum, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 28, 2009
Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variablesA Kornberg, B Küpper, A Tannapfel, et al.
Transplantation Proceedings|December 20, 2007
Oral tacrolimus bioavailability is increased after right split liver transplantationJ Wilberg, B Küpper, K Thrum, et al.
Transplantation Proceedings|September 1, 2009
Increased 18F-FDG uptake of hepatocellular carcinoma on positron emission tomography independently predicts tumor recurrence in liver transplant patientsA Kornberg, B Küpper, K Thrum, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 22, 2007
Conversion to mycophenolate mofetil for modulating recurrent hepatitis C in liver transplant recipientsA Kornberg, B Küpper, J Wilberg, et al.
Digestive Diseases and Sciences|September 9, 2010
Sustained renal response to mycophenolate mofetil and CNI taper promotes survival in liver transplant patients with CNI-related renal dysfunctionA Kornberg, B Küpper, K Thrum, et al.
Pageof 1